Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
havasu78's Profile
Displaying 151-200 of 491 result(s).
CYDY CytoDyn Inc
03/04/2021 11:13:22 PM
yes, patterson/yo use ivernectin he (2)
CYDY CytoDyn Inc
02/27/2021 10:35:37 PM
Borel, what PR is that data from? I
CYDY CytoDyn Inc
02/25/2021 11:51:15 PM
yes that graph is the LL blood conc (5)
CYDY CytoDyn Inc
02/25/2021 3:26:13 PM
I can't find anywhere in Dr. Yang's (9)
CYDY CytoDyn Inc
02/21/2021 6:00:52 PM
Certainly an interesting thread the (2)
CYDY CytoDyn Inc
02/21/2021 1:39:14 PM
i think the succes of the Patterson (3)
CYDY CytoDyn Inc
02/20/2021 8:37:24 PM
Seems to me a sales and marketing t (2)
CYDY CytoDyn Inc
02/20/2021 8:10:17 PM
"The p-value is: 0.000328" That is
CYDY CytoDyn Inc
02/20/2021 1:48:57 AM
Patterson's iWatch wanna-be is cert (12)
CYDY CytoDyn Inc
02/20/2021 12:22:09 AM
Patterson has an iWatch competitor. (2)
CYDY CytoDyn Inc
02/20/2021 12:17:10 AM
CCR5delta32 genotyping in the Yo/Pa (2)
CYDY CytoDyn Inc
02/20/2021 12:13:08 AM
Apologies if this has been posted b (7)
CYDY CytoDyn Inc
02/19/2021 1:11:53 PM
Way to go, Cdidy:) I say keep up th (1)
CYDY CytoDyn Inc
02/16/2021 1:23:07 PM
I am just trying to understand what
CYDY CytoDyn Inc
02/16/2021 11:51:20 AM
"Those patients are from the avipta (1)
CYDY CytoDyn Inc
02/16/2021 12:25:55 AM
If you look at figure 5 in the BRPA (1)
CYDY CytoDyn Inc
02/16/2021 12:17:16 AM
Aviptadil primary endpoint is a don (7)
CYDY CytoDyn Inc
02/15/2021 7:03:07 PM
Here are some Aviptadil plots, cour (3)
CYDY CytoDyn Inc
02/15/2021 3:07:56 PM
Totally agree all your scenarios ar (6)
CYDY CytoDyn Inc
02/15/2021 2:28:59 PM
CYDY commercial success in non-covi (1)
CYDY CytoDyn Inc
02/15/2021 2:15:41 PM
No way will anyone sell billions of (3)
CYDY CytoDyn Inc
02/15/2021 2:09:57 PM
Yes, severe vs. critical is certain (1)
CYDY CytoDyn Inc
02/14/2021 11:28:16 PM
Thanks enjay. Does seem a good reas (1)
CYDY CytoDyn Inc
02/14/2021 10:14:47 PM
FWIW, probably nothing, i think tho (2)
CYDY CytoDyn Inc
02/14/2021 9:45:00 PM
" I am aware of one large hospital
CYDY CytoDyn Inc
02/07/2021 2:15:02 PM
Treating Covid might not be moving (8)
CYDY CytoDyn Inc
02/06/2021 9:00:11 PM
Thanks for reposting, Techguru. The (2)
CYDY CytoDyn Inc
02/06/2021 2:25:10 AM
I disagree that Pourhassan, Kelly, (9)
CYDY CytoDyn Inc
02/05/2021 8:22:56 PM
123, i was not criticizing Nader fo (19)
CYDY CytoDyn Inc
02/04/2021 6:55:16 PM
Indeed if LL suppresses PDL1 in can (1)
CYDY CytoDyn Inc
02/04/2021 6:36:48 PM
My god, I knew I was near clueless, (4)
CYDY CytoDyn Inc
02/04/2021 6:17:17 PM
That job posting is probably an exa
CYDY CytoDyn Inc
02/04/2021 6:11:10 PM
Don't really know what I'm talking (2)
CYDY CytoDyn Inc
02/04/2021 4:41:12 PM
BMS-813160 is a walking, talking ad (4)
CYDY CytoDyn Inc
02/03/2021 1:22:23 PM
S2 = (10*IL-10 + IL-6) - (IL-2 + IL
CYDY CytoDyn Inc
02/02/2021 10:08:39 PM
Key question: Can poker-faced Nader (9)
CYDY CytoDyn Inc
02/02/2021 9:45:14 PM
"CDC" is NOT the US Centers for Dis (3)
CYDY CytoDyn Inc
02/02/2021 9:40:20 PM
Dr. Randy Nicholas is a Phillippine (6)
CYDY CytoDyn Inc
01/30/2021 10:03:13 PM
As Nader mentioned Thursday evening (4)
CYDY CytoDyn Inc
01/30/2021 11:38:42 AM
LOL sorry chazzle i really had no i
CYDY CytoDyn Inc
01/29/2021 10:45:17 PM
Indeed a very interesting group of (10)
CYDY CytoDyn Inc
01/27/2021 9:29:55 PM
There are no distribution costs. Th
CYDY CytoDyn Inc
01/27/2021 1:03:05 PM
thanks borel. ok so seven point ord (1)
CYDY CytoDyn Inc
01/26/2021 9:28:51 PM
Thanks CT. I started at the newest
CYDY CytoDyn Inc
01/26/2021 9:19:36 PM
Saying Patterson "schooled" the oth (9)
CYDY CytoDyn Inc
01/26/2021 8:50:35 PM
I was at first skeptical that the a (1)
CYDY CytoDyn Inc
01/26/2021 1:18:03 PM
I thought the same thing too, but c (1)
CYDY CytoDyn Inc
01/24/2021 1:40:51 AM
Thanks that makes sense. I have no (1)
CYDY CytoDyn Inc
01/24/2021 12:27:45 AM
I think its good, too, but the tech (1)
CYDY CytoDyn Inc
01/24/2021 12:19:22 AM
So does the patient illness even fu (3)
Go to page:
  • << First
  • < Previous
  • 3
  • 4
  • Next >

Recent Articles

  • Defense Metals Advances Wicheeda Project with Strategic Plans
  • Dave Ramsey: Three Core Investments for Financial Stability
  • AMD's Bold AI Partnership: CEO Sees Massive Financial Gains Ahead
  • Duck Creek Technologies' Annual Summit Emphasizes Inclusion
  • Cryptocurrency Market Surge: A Deep Dive into Trends and Stakes
  • Stock Market Highlights: AMD, AppLovin, Trilogy Metals, Nike, Verizon
  • ONEOK Facility Incident Update: Safety Measures in Action
  • Exploring the Future Growth of the Green Ammonia Market
  • Cathie Wood's Latest Trading Moves: Heavy Investments Explained
  • Exploring MoonLake Immunotherapeutics: A Dive into Recent Investigations
  • Join the Investigation into MoonLake Immunotherapeutics Claims
  • GOFO Unveils State-of-the-Art Logistics Facility in New Jersey
  • AmgenNow Program Enhances Access to Repatha for Patients
  • Consumer Guardian Group Expands Support for Timeshare Owners
  • Empowering Investors: Join Legal Action Against Fly-E Group
  • Know Your Rights: Class Action Update for Charter Investors
  • KBR, Inc. Faces Securities Fraud Class Action Lawsuit
  • Shaquille O'Neal Delivers Joy in Hershey at Special Events
  • Grupo Simec Enhances Financial Transparency with Form 20-F Amendment
  • Trilogy Metals Celebrates Approval of Ambler Access Project
  • Dr. James A. Tompkins Rejoins Tompkins Solutions as Chairman
  • Vinitaly.USA 2025: Celebrating Italian Wine in Chicago
  • Unveiling the Surprising Stock Picks of Famous Investors
  • Discover How a $100 Investment in Charles Schwab Has Grown
  • Transforming $1000 into $16364 with F5 Stock Investment
  • Investors Unite: Join the Spirit Aviation Legal Challenge
  • GAIM.FUN's Innovative Funding to Transform Virtual Worlds
  • Eagle Pharmaceuticals Shares First Quarter Financial Overview
  • Verde AgriTech Unveils Major Rare Earth Discovery in Brazil
  • Fortinet Investors Urged to Act Amidst Class Action Lawsuit
  • Incredible Growth of First BanCorp: A Decade of Investment Success
  • Understanding the KinderCare Learning Companies Class Action
  • Mesoblast's Ryoncil Sales Surge with Impressive Growth
  • Join the Fight for Justice with Spirit Aviation Holdings, Inc.
  • Qualtrics' Bold Move to Transform Experience Management with Forsta
  • Mesoblast's Ryoncil® Achieves Remarkable Revenue Growth
  • Investing in Growth: An Insight into GMO’s DRES ETF
  • FLYE Investors Face Securities Fraud Lawsuit Opportunity
  • KBR, Inc. Shareholders Urged to Act on Class Action Case
  • Understanding the Class Action Against Jasper Therapeutics and JSPR
  • Fortinet, Inc. Class Action Update: Important Investor Insights
  • LuxUrban Securities Case: Key Allegations Dismissed by Court
  • AEG Europe Leads the Charge in Sustainable Power for UK Venues
  • Qualigen Therapeutics Strengthens Leadership with Key Appointments
  • Legal Counsel Alert for Unicycive Therapeutics Inc. Investors
  • Transforming $100 Into $670: The InterDigital Investment Journey
  • Cytokinetics Inc. Investors Get Ready for Lead Plaintiff Deadline
  • Understanding the Spirit Aviation Holdings Class Action Lawsuit
  • Investors Take Note: Class Action Against Quanex Building Products
  • Investors Alert: Class Action Against RCI Hospitality Holdings
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site